Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    Collaborating with questionnaire authors.
    The most trusted distributor of COAs

    800+ exclusive COA distributions on behalf of their copyright owners

    Author discussing assessment development.
    PROQOLID™: the largest COA database

    8,400+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    Team reviewing questionnaire content.
    About ePROVIDE™

    Online access to all our services and COA databases

    Working on validation studies.
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    Author Resources COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    Reviewing translated assessments.
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    Developing new PRO instruments.
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    Scientific meeting about COAs.
    News
    Meeting with instrument developers.
    Conferences
    Discussion about PRO measures.
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments (COAs).

    Read More
    Collaborative research session.
    Team

    A global team of multi-disciplinary experts

    Team analyzing PRO data.
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. Resources
  3. Blog
  4. The missing endpoint? Bringing caregiver impact into treatment benefit assessment

The missing endpoint? Bringing caregiver impact into treatment benefit assessment

Page tools
Share Share
Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Facebook

Share on X

Facebook

Share on Facebook

Behind many patients is a caregiver whose daily life is also shaped by the disease and its management.

For many caregivers, providing care is a valued and meaningful part of supporting someone close to them, not something they would describe as a burden. Yet caregiving can have important consequences on physical and emotional well-being, social and family life, work and finances.

Caregivers may also play a critical role in treatment management, from administering therapies and monitoring symptoms to coordinating appointments and navigating healthcare services.

Historically, caregiver research has often focused on the concept of caregiver burden. Today, the perspective is broadening toward caregiver impact, recognizing the multidimensional experience of caregiving and its consequences across different aspects of caregivers' lives. Assessing caregiver impact alongside patient outcomes can provide a broader understanding of a treatment’s effects and benefits.

If caregivers are integral to the disease and treatment journey, how can we better capture their experience within clinical research?

Caregiving: One role. Many different experiences

Interest in the caregiver experience is not new. What is changing is the extent to which it is being recognized and measured across health research.

To explore this evolution, we reviewed the PROQOLID™ database and published literature to identify clinical outcome assessments (COAs) addressing caregiver burden or the broader impact of caregiving. Our analysis, presented at ISPOR Europe 2026, confirms a clear expansion of caregiver-focused measurement, with more than half of identified COAs developed since 2010.

The landscape is also becoming increasingly disease-focused, with more than three-quarters of the COAs identified between 2015 and 2025 disease-specific.

Caregiving is not a single experience. A parent supporting a child with a rare disease, a person caring for someone with cancer, and someone supporting an adult with a progressive neurological condition may have very different responsibilities and face diverse challenges.

The caregiver relationship, disease, treatment, stage of disease and organization of care can all shape that experience. The concepts relevant to its assessment may therefore differ, encompassing physical health, emotional well-being, quality of life, family and social functioning, work and productivity, financial impacts, or the demands associated with treatment management.

The diversity of available COAs reflects these different dimensions of caregiving. The Zarit Burden Interview (ZBI-22), for example, assesses caregivers' subjective feelings of burden. Other COAs focus on specific dimensions of impact: the Caregiver Work Limitations Questionnaire (Caregiver WLQ) addresses work performance and productivity, while the Caregiver Quality of Life Questionnaire (CQLQ) focuses on physical and emotional quality of life.

For clinical trial designers and patient-centricity teams, this means that “Which caregiver questionnaire should we use?” may not be the right question to start with. A better starting point is: What do we need to understand about the caregiver experience in this study?

Some therapeutic areas are further ahead

Our analysis also shows that attention to caregiver measurement has not progressed equally across therapeutic areas.

Caregiver-focused COA development has been particularly prominent in central nervous system disorders, cancer and mental health, which together represented more than half of the disease-specific COAs identified.

These are areas where the role and experience of caregivers have already received substantial attention. Guidance identified through a search of PROINSIGHT™, Mapi Research Trust’s database of regulatory and HTA guidance, provides an example. In its 2022 evidence review on the pharmacological management of spasticity in multiple sclerosis, NICE identified the impact on patients and carers among the outcomes considered critically important for decision-making.

But this pattern also raises questions about other therapeutic areas where caregiving may be integral to the patient journey but has been less systematically explored.

Pediatric caregiving provides a particularly relevant example. In our analysis, 29% of caregiver-focused COAs targeted caregivers of children or adolescents.

Yet pediatric caregivers may have specific responsibilities, including administering treatments, monitoring symptoms, coordinating care and schooling, and reorganizing work and family routines. Some COAs have been developed specifically to capture these experiences. For example, the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) assesses the experience of caregivers of children with neuromuscular disease.

Better understanding the pediatric caregiving experience, alongside developing appropriate caregiver-focused COAs where gaps remain, represents an important opportunity for future research.

From “which questionnaire?” to “what do we need to understand?”

As caregiver impact receives greater attention, the starting point for measurement should remain the caregiver experience itself.

For clinical trial designers and patient-centricity experts, a few questions can help structure that thinking:

  • Who are the caregivers in this population?
  • How does the disease or treatment affect their lives?
  • What role do they play in treatment and disease management?
  • Which aspects of their experience are most relevant to the research question?
  • Are those concepts already covered by an existing COA?

Once potentially relevant COAs have been identified, their suitability can be assessed against the intended population, concepts of interest and context of use.

Explore caregiver-focused COAs in PROQOLID™

Understanding what has already been measured is a practical first step.

PROQOLID™ can help you explore caregiver-focused COAs across diseases, populations and concepts, and identify potential COAs for further evaluation in your research context.

Explore caregiver-focused COAs in PROQOLID™ using search terms such as “caregiver burden” or “caregiver impact” or “Impact on caregivers”, and discover what has already been measured in your research context.

Explore PROQOLID™

Thank you to Céline Desvignes-Gleizes and Nadine Kraft for their contributions to this article.

In this section
In this section
  • Blog
  • Publications
    • PROQOLID
    • PROLABELS
    • Literature Review
    • Intellectual Property, copyright issues, and distribution of Patient-Centered Outcomes
    • Translation & Linguistic validation
    • Therapeutic areas
      • Digestive health, gastroenterology, metabolism
      • Endocrinology
      • General
      • Gynecology
      • Hematology
      • Infectious disease, immunology, vaccines
      • Ophthalmology
      • Pain
      • Psychiatry-psychology
      • Rare Diseases
      • Respiratory
      • Rheumatology–musculoskeletal disorders
      • Urology
    • Cochrane HRQoL Methods Group
    • Development projects
    • Education
    • ERIQA/PRO harmonization
    • IQOD
  • Useful links
  • Webinar recordings
  • Whitepapers
    • Whitepaper | COAs and copyright
    • The COA licensing process: How to prepare for success
    • Whitepaper | Digitizing COAs: A streamlined approach to approval
Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2026 Mapi Research Trust
  • Disclaimer
  • Privacy
  • Site Cookies
  • Sitemap